Current development of siRNA bioconjugates: from research to the clinic

IV Chernikov, VV Vlassov… - Frontiers in …, 2019 - frontiersin.org
Small interfering RNAs (siRNAs) acting via RNA interference mechanisms are able to
recognize a homologous mRNA sequence in the cell and induce its degradation. The main …

Regulation of small RNA stability: methylation and beyond

L Ji, X Chen - Cell research, 2012 - nature.com
As central components of RNA silencing, small RNAs play diverse and important roles in
many biological processes in eukaryotes. Aberrant reduction or elevation in the levels of …

Progress toward in vivo use of siRNAs-II

GR Rettig, MA Behlke - Molecular therapy, 2012 - cell.com
RNA interference (RNAi) has been extensively employed for in vivo research since its use
was first demonstrated in mammalian cells 10 years ago. Design rules have improved, and it …

Development of therapeutic-grade small interfering RNAs by chemical engineering

JB Bramsen, J Kjems - Frontiers in genetics, 2012 - frontiersin.org
Recent successes in clinical trials have provided important proof of concept that small
interfering RNAs (siRNAs) indeed constitute a new promising class of therapeutics. Although …

Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics

GR Kokil, RN Veedu, GA Ramm, JB Prins… - Chemical …, 2015 - ACS Publications
Figures released in 2013 by the International Diabetes Federation (IDF) state that over 382
million individuals worldwide are affected by diabetes mellitus (DM). 1 The global …

Antisense oligonucleotides internally labeled with peptides show improved target recognition and stability to enzymatic degradation

M Taskova, CS Madsen, KJ Jensen… - Bioconjugate …, 2017 - ACS Publications
Specific target binding and stability in diverse biological media is of crucial importance for
applications of synthetic oligonucleotides as diagnostic and therapeutic tools. So far, these …

[HTML][HTML] Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses

B Tolksdorf, J Heinze, D Niemeyer, V Röhrs, J Berg… - Antiviral Research, 2024 - Elsevier
Abstract Treatment options for COVID-19 remain limited. Here, we report the optimization of
an siRNA targeting the highly conserved leader region of SARS-CoV-2. The siRNA was …

Improved siRNA/shRNA functionality by mismatched duplex

H Wu, H Ma, C Ye, D Ramirez, S Chen, J Montoya… - PloS one, 2011 - journals.plos.org
siRNA (small interfering RNA) and shRNA (small hairpin RNA) are powerful and commonly
used tools in biomedical research. Currently, siRNAs are generally designed as two 21 nt …

Dual miRNases for triple incision of miRNA target: design concept and catalytic performance

O Patutina, D Chiglintseva, E Bichenkova, S Gaponova… - Molecules, 2020 - mdpi.com
Irreversible destruction of disease-associated regulatory RNA sequences offers exciting
opportunities for safe and powerful therapeutic interventions against human …

Chemical modifications in RNA interference and CRISPR/Cas genome editing reagents

KA Lennox, MA Behlke - RNA Interference and CRISPR Technologies …, 2020 - Springer
Chemically modified oligonucleotides (ONs) are routinely used in the laboratory to assess
gene function, and clinical advances are rapidly progressing as continual efforts are being …